At the news
? BEARISHIMPACT 6/10 144 filed Apr 20, 2026 at 16:44 ET
Two affiliated venture funds, Atlas Venture Fund XI and Atlas Venture Opportunity Fund I, filed Form 144 notices to sell a combined 198,926 shares of Dyne Therapeutics stock, representing an intent to sell approximately $2.9 million worth of shares. The sales are planned under Rule 144 following private placement acquisitions in 2020.
- Atlas Venture Fund XI filed to sell 142,571 shares, valued at approximately $2.05 million based on recent market price
- Atlas Venture Opportunity Fund I filed to sell 56,355 shares, valued at approximately $815,000
- Total proposed sale: 198,926 shares worth ~$2.87 million
- Shares were acquired in private placements in July and August 2020
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access